Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Clinial Trials

- PMLiVE

Ann Barbier joins Translate Bio as its chief medical officer

She will take responsibility for leading the US biotech's clinical R&D

Orion appoints VP of oncology, R&D

Professor Heikki Joensuu joins from Helsinki University Hospital

- PMLiVE

Adding value in emerging markets

What benefit do branded generics bring to patients around the world?

- PMLiVE

A new picture

Changing the route to brand growth

- PMLiVE

Another well-deserved promotion at Porterhouse Medical

We are delighted to announce the promotion of one of our scientific staff, Emma, to the role of senior medical writer. Not only was Emma the winner of our 2016 Entrepreneur...

Porterhouse Medical Group

- PMLiVE

First digital medicine approved in the US

The antipsychotic drug has a built-in digital tracking sensor

- PMLiVE

Boehringer claims EU okay for Humira biosimilar

But won’t launch before expiration of the respective SPC for adalimumab in October 2018

- PMLiVE

Fujifilm expands biopharma development and manufacturing business

Company invests 3.2bn yen in US and UK sites

- PMLiVE

Zelluna appoints Miguel Forte as CEO

He joins the Norwegian biotech from Bone Therapeutics

- PMLiVE

Storm Therapeutics strengthens its board

Professor Paul Workman joins as an independent director

- PMLiVE

If a nudge doesn’t last forever, how do we ensure sustained behaviour change?

Changing behaviour isn’t easy, but maintaining behaviour change is even harder.We know that by the tiny number of New Year’s resolutions we actually manage to keep, the number of gym...

AstraZeneca AZ

AZ severe asthma drug benralizumab backed by CHMP

The IL-5 inhibitor set for European approval to treat severe eosinophilic asthma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links